Genenta Science S.p.A. Operating Income Loss

• Genenta Science S.p.A. showed an increase of +16.8% in Operating Income Loss from 2023 to 2024.
• This data is from Genenta Science S.p.A.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
• XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2019 to 2024), Genenta Science S.p.A.'s Operating Income Loss has declined by 111.1%.
• Historical annual values: Fiscal year 2024: -$9.76 million | Fiscal year 2023: -$11.73 million | Fiscal year 2022: -$11.04 million | Fiscal year 2021: -$5.69 million | Fiscal year 2020: -$5.59 million | Fiscal year 2019: -$4.62 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026